Acromesomelic Dysplasia, Hunter-Thompson Type

What is Acromesomelic Dysplasia, Hunter-Thompson Type?

Acromesomelic Dysplasia, Hunter-Thompson Type is a rare disease. It is also known as Acromesomelic Dwarfism Amdh Campailla-Martinelli mesomelia Maroteaux acromesomelic dysplasia.

Acromesomelic dysplasia, type Maroteaux (AMDM) is a rare autosomal recessive skeletal dysplasia which belongs to the group of acromesomelic dysplasias (Maroteaux et al., 1971; Langer and Garrett, 1980). AMDM is characterized by severe dwarfism with disproportionate shortening of the extremities and spine, predominantly affecting the middle and distal segments of limbs (Langer and Garrett, 1980; Saadullah et al., 2012). Birth lengths and radiographs are normal in AMDM newborns, but skeletal growth is decelerated after birth due to abnormal endochondral ossification and results in severe short stature (Langer and Garrett, 1980; Borrelli et al., 1983; Saadullah et al., 2012).
The short stature might be noted at birth but mostly becomes obvious during the first year of life. The forearms are bowed and the fingers and toes are very short. The head is relatively large with frontal bossing. The radial head might be dislocated. Eventual stature is below the 3rd centile. Delayed gonadal function has been reported in some patients and very occasionally corneal ulcers have occurred. Radiologically there are short and broad proximal and middle phalanges, cone shaped epiphyses and invaginated metaphyses. The forearm bones are shorter than the humerus. The vertebral bodies have a central anterior protrusion. Many cases appear to be autosomal recessive but Ohba et al. (1989) reported an affected father and son, suggesting possible autosomal dominant inheritance. Minty and Hall (1993) reported a brother and sister with the condition who both had hypomagnesaemia. The brother also had hypocalcaemia that responded to oral calcium supplements.
Ferraz et al., (1997) reported an affected mother and son with what they felt was a variant form of the condition. The radii were curved and there was unusual slight angulation of the distal ulnar in the mother. The hands were short with marked shortening of the second and fifth fingers.
A good review of the genetics of the condition is provided. Kant et al., (1998) mapped the gene to 9p13-9q12. Faivre et al., (2000) reported linkage of the gene to 9p13-q12 in four consanguineous families, but exclusion of linkage in a fifth family with a mild form of the disease. Ianakiev et al., (2000) also mapped the gene to the pericentromeric region of chromosome 9 in a families from the isolated islands of St Helena.
No organ systems are affected in AMDM patients other than the skeletal system (Bartels et al., 2004; Pagel-Langenickel et al., 2007). X-rays show short, broad fingers, square, flat feet, and shortening of the long bones (particularly the forearms). The radius is bowed, the ulna is shorter than the radius, and its distal end is occasionally hypoplastic. The skull is dolichocephalic and a shortness of the trunk, with decreased vertebral height and narrowing of the lumbar interpedicular distances, is consistently observed. The facial appearance and intelligence are normal (Langer and Garrett, 1980; Faivre et al., 2000).
Compound heterozygous or homozygous mutations of NPR2 have been found to be responsible for AMDM (Bartels et al., 2004; Saadullah et al., 2012). According to Wang et al. (2015), 29 functional sequence variants associated with AMDM in the NPR2 gene had been reported by 2015 (Bartels et al., 2004; Hachiya et al., 2007; Castro-Feijóo et al., 2012; Khan et al., 2012).
Wang et al. (2016) presented three additional individuals with the AMDM phenotype caused by compound heterozygous or homozygous loss-of-function mutations in the NPR2 gene. All of them had short stature. One individual had elbow stiffness. Their intelligence and cognitive development were normal. The following features were observed: markedly short upper and lower extremities, brachydactyly, macrodactyly of the great toes and relatively tiny toes, radial head dislocation and flexion contracture of both elbow joints. Radiographs revealed mesomelic shortening, metatarsal and phalanges of the big toes longer than those of other toes, cone-shaped phalangeal epiphyses, bilateral dysplastic acetabula, platyspondyly of thoracolumbar spine with wedging of vertebral bodies posteriorly and spinal canal stenosis, and widening of the metaphyses in the distal femur and proximal tibia.

Read More

* This information is courtesy of the L M D.

If you find a mistake or would like to contribute additional information, please email us at: [email protected]

What gene changes cause Acromesomelic Dysplasia, Hunter-Thompson Type?

The syndrome is inherited in the following inheritance pattern/s:

Autosomal Recessive - Autosomal recessive inheritance means an affected individual receives one copy of a mutated gene from each of their parents, giving them two copies of a mutated gene. Parents, who carry only one copy of the gene mutation will not generally show any symptoms but have a 25% chance of passing the copies of the gene mutations onto each of their children.

Autosomal Dominant - In the case of autosomal dominant inheritance, just one parent is the carrier of the gene mutation, and they have a 50% chance of passing it onto each of their children. Syndromes inherited in an autosomal dominant inheritance are caused by just one copy of the gene mutation.

In some cases, a genetic syndrome may be the result of a de-novo mutation and the first case in a family. In this case, this is a new gene mutation that occurs during the reproductive process.

OMIM Number - 201250 (please check the OMIM page for updated information)

The syndrome can be caused by mutations in the following gene/s location/s:
GDF5 - 20q11.22
NPR2 - 9p13.3

What are the main symptoms of Acromesomelic Dysplasia, Hunter-Thompson Type?

The typical symptoms of the syndrome are:
Micromelia, Neurological speech impairment, Single transverse palmar crease, Autosomal recessive inheritance, Short foot, Hypoplasia of the radius, Short tibia, Short thumb, Hypoplasia of the ulna, Short stature, Cognitive impairment, Fibular hypoplasia, Limitation of joint mobility, Elbow dislocation, Brachydactyly, Distal femoral bowing, Shortening of all middle phalanges of the fingers, Patellar dislocation, Hip dislocation, Tarsal synostosis, Severe short-limb dwarfism, Cuboidal metacarpal, Shortening of all proximal phalanges of the fingers, Radial bowing, Scoliosis, Acromesomelia, Abnormality of the hip bone, Abnormality of the ankles, Abnormally shaped carpal bones, Abnormality of the wrist

How does someone get tested for Acromesomelic Dysplasia, Hunter-Thompson Type?

The initial testing for Acromesomelic Dysplasia, Hunter-Thompson Type can begin with facial genetic analysis screening, through the FDNA Telehealth telegenetics platform, which can identify the key markers of the syndrome and outline the type of genetic testing needed. A consultation with a genetic counselor and then a geneticist will follow.

Based on this clinical consultation with a geneticist, the different options for genetic testing will be shared and consent will be sought for further testing.

Get Faster and More Accurate Genetic Diagnosis!

More than 250,000 patients successfully analyzed!
Don't wait years for a diagnosis. Act now and save valuable time.

Start Here!

"Our road to a rare disease diagnosis was a 5-year journey that I can only describe as trying to take a road trip with no map. We didn’t know our starting point. We didn’t know our destination. Now we have hope."


Paula and Bobby
Parents of Lillie

What is FDNA Telehealth?

FDNA Telehealth is a leading digital health company that provides faster access to accurate genetic analysis.

With a hospital technology recommended by leading geneticists, our unique platform connects patients with genetic experts to answer their most pressing questions and clarify any concerns they may have about their symptoms.

Benefits of FDNA Telehealth

FDNA icon


Our platform is currently used by over 70% of geneticists and has been used to diagnose over 250,000 patients worldwide.

FDNA icon


FDNA Telehealth provides facial analysis and screening in minutes, followed by fast access to genetic counselors and geneticists.

FDNA icon

Ease of Use

Our seamless process begins with an initial online diagnosis by a genetic counselor and follows by consultations with geneticists and genetic testing.

FDNA icon

Accuracy & Precision

Advanced artificial intelligence (AI) capabilities and technology with a 90% accuracy rate for a more accurate genetic analysis.

FDNA icon

Value for

Faster access to genetic counselors, geneticists, genetic testing, and a diagnosis. As fast as within 24 hours if required. Save time and money.

FDNA icon

Privacy & Security

We guarantee the utmost protection of all images and patient information. Your data is always safe, secure, and encrypted.

FDNA Telehealth can bring you closer to a diagnosis.
Schedule an online genetic counseling meeting within 72 hours!